Galactica Biotech
Galactica Biotech is an innovative company utilizing advanced analytical methods, including machine learning, to identify new uses for molecules. Their mission is to set new standards in the pharmaceutical industry by adding value to drugs and improving health outcomes. They focus on drug repurposing, virtual screening, and binding site identification, aiming to reduce risks and costs for companies while accelerating drug development. Their technology is currently generating a pipeline of therapeutic molecules for various diseases, showcasing their commitment to innovation and excellence in the field.
Galactica Biotech
Galactica Biotech is an innovative company utilizing advanced analytical methods, including machine learning, to identify new uses for molecules. Their mission is to set new standards in the pharmaceutical industry by adding value to drugs and improving health outcomes. They focus on drug repurposing, virtual screening, and binding site identification, aiming to reduce risks and costs for companies while accelerating drug development. Their technology is currently generating a pipeline of therapeutic molecules for various diseases, showcasing their commitment to innovation and excellence in the field.
TL;DR
Headquarters: Cork, Ireland
Founded: 2017
Core tech: Machine-learning driven drug repurposing and virtual screening
Seed investors: SOSV (lead), RebelBio
Employee count (reported): 1
Company Overview
Problem Domain
Drug repurposing/repositioning, virtual screening, binding-site identification
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Seed round with investors RebelBio and SOSV (SOSV listed as lead).
Investor Signal
“SOSV and RebelBio participated in a seed round”